Objective The aim of this study was to assess the epidemiological and clinical characteristics of herpes zoster (HZ) and to ...

Background/objective To reduce the risk of hydroxychloroquine (HCQ)-induced retinopathy, the American Academy of ...

Objective Systemic lupus erythematosus (SLE) primarily affects women of reproductive age, necessitating complex conversations ...

Objective Early prediction of long-term outcomes in patients with systemic lupus erythematosus (SLE) remains a great challenge in clinical practice. Our study aims to develop and validate predictive ...

Objective To evaluate the efficacy of mepacrine (MC) as an add-on therapy in patients with SLE unresponsive to hydroxychloroquine (HCQ)-containing regimens at 6 months after MC introduction. Methods ...

Objective SLE is a complex, heterogenous autoimmune disease. SLE researchers do not always collect the same data, making comparative studies difficult. We aimed to ascertain what variables SLE ...

Objective Recent studies reported that SLE is characterised by altered interactions between the microbiome and immune system. We performed a meta-analysis of publications on this topic. Methods ...

Objectives The 2023 EULAR recommendations for the management of SLE endorse stratifying disease activity into mild, moderate, and severe categories to guide treat-to-target (T2T) strategies. Both ...

Objective To compare patients with SLE associated with either Evans syndrome (ES) or an isolated autoimmune cytopenia (immune thrombocytopenia (ITP) or autoimmune haemolytic anaemia (AIHA)). Methods ...

Objectives To characterise the clinical presentation, laboratory findings, treatment approaches, and outcomes of systemic lupus erythematosus (SLE)-associated macrophage activation syndrome (MAS), and ...

Background Emerging evidences indicate that a distinct CD11c+T-bet+ B cell subset termed age/autoimmune-associated B cells (ABCs) is the major pathogenic autoantibody producer in lupus. Human lupus is ...

Objectives Up 50% of pregnancies in women with systemic lupus erythematosus (SLE) is complicated by adverse outcomes, such as preterm birth, fetal growth restriction and pre-eclampsia. The underlying ...